PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31123968-0	2019	Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis.	Celecoxib	30-39	suppressor of cytokine signaling 3	Homo sapiens	115-120	
31123968-5	2019	Cilostazol and celecoxib cotreatment similarly showed synergistic increase in SOCS3 mRNA levels.	Celecoxib	15-24	suppressor of cytokine signaling 3	Homo sapiens	78-83	
31123968-8	2019	Summarizing, cotreatment with cilostazol and celecoxib exhibited a synergistic increase in IL-10 production and SOCS3 expressions, thereby resulted in synergistic decreases in IL-1beta mRNA, IL-6 mRNA expression and TNF-alpha synthesis in association with synergistic decreases in COX-2 and PGE2 protein expression in the RA synovial fibroblasts.	Celecoxib	45-54	suppressor of cytokine signaling 3	Homo sapiens	112-117